Abstract
Our aim was to investigate the impact of sodium glucose cotransporter type 2 (SGLT2) inhibitor on left ventricular (LV) diastolic function in type 2 diabetes mellitus (T2DM) patients with heart failure (HF) complicating cardiovascular risk factors. We analyzed data from our previous prospective
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
